We confirmed the myocardial protective and neuroprotective effects of XPF in treating CHD with depression, which was associated with its activation of the cAMP signaling pathway and inhibition of myocardium and hippocampus apoptosis. This evidence concerns the gene ERCC4 and depressive disorder.